DANIMER SCIENTIFIC INC (DNMR) Forecast, Price Target & Analyst Ratings
NYSE:DNMR • US2362721001
4.13 USD
-0.59 (-12.5%)
Last: Dec 30, 2024, 08:08 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DANIMER SCIENTIFIC INC (DNMR).
Forecast Snapshot
Consensus Price Target
$4.76
+ 15.26% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2024
EPS Estimate-$6.60
Revenue Estimate11.266M
ChartMill Buy Consensus
45.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.76
Upside
+ 15.26%
From current price of $4.13 to mean target of $4.76, Based on 8 analyst forecasts
Low
$4.04
Median
$4.59
High
$5.78
Price Target Revisions
1 Month
-15.15%
3 Months
449.02%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for DNMR. The average price target is 4.76 USD. This implies a price increase of 15.25% is expected in the next year compared to the current price of 4.13.
The average price target has been revised upward by 449.02% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.00%
DNMR was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about DNMR.
In the previous month the buy percentage consensus was at a similar level.
DNMR was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-08-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-05-22 | Jefferies | Downgrade | Buy -> Hold |
| 2024-04-09 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-04-04 | TD Cowen | Maintains | Buy -> Buy |
| 2023-10-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-06-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-04-03 | Piper Sandler | Maintains | Overweight |
| 2022-10-12 | Piper Sandler | Initiate | Overweight |
| 2021-09-23 | Cowen & Co. | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2024
EPS Estimate-$6.60
Revenue Estimate11.266M
Revenue Q2Q2.93%
EPS Q2Q-1,591.28%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-53.05%
EPS (1 Month)
0.00%
EPS (3 Months)
-3,326.05%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 53.05% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 58.75M 24.13% | 53.22M -9.41% | 46.684M -12.28% | 42.672M -8.59% | 90.994M 113.24% | 188.85M 107.54% | 350.88M 85.80% | 430.44M 22.67% | 506.94M 17.77% | 637.5M 25.75% | |
| EBITDA YoY % growth | -87.72M -688.14% | -103.49M -17.98% | -95.808M 7.42% | -35.477M 62.97% | -5.407M 84.76% | 10.593M 295.92% | 70.38M 564.40% | 121.38M 72.46% | 147.9M 21.85% | 99.96M -32.41% | |
| EBIT YoY % growth | -99.39M -531.45% | -123.94M -24.70% | -125.185M -1.00% | -70.563M 43.63% | -36.926M 47.67% | -18.544M 49.78% | 19.38M 204.51% | 73.44M 278.95% | 100.98M 37.50% | 32.64M -67.68% | |
| Operating Margin | -169.17% | -232.88% | -268.15% | -165.36% | -40.58% | -9.82% | 5.52% | 17.06% | 19.92% | 5.12% | |
| EPS YoY % growth | -0.91 -104.75% | -1.78 -95.60% | -1.52 14.61% | -32.07 -2,009.57% | -19.50 39.19% | -13.72 29.62% | -0.36 97.40% | 0.51 242.86% | 0.46 -10.00% | 0.15 -66.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -6.60 -1,591.28% | -6.29 -2,320.54% | -5.62 26.09% | -3.85 19.75% | -3.74 43.30% | -0.57 90.94% | -0.33 94.04% | -0.28 92.64% | -0.25 93.43% |
| Revenue Q2Q % growth | 11.266M 2.93% | 14.28M 39.67% | 18.6M 143.84% | 22.103M 156.12% | 25.454M 125.94% | 28.509M 99.64% | 32.671M 75.65% | 36.832M 66.64% | 41.004M 61.09% |
| EBITDA Q2Q % growth | -7.413M -409.47% | -3.742M 65.95% | -2.46M 35.18% | 532.44K -85.16% | 4.304M 158.06% | 2.171M 158.01% | 4.117M 267.38% | 4.638M 771.08% | 5.159M 19.87% |
| EBIT Q2Q % growth | -15.435M 49.94% | -13.501M 27.11% | -12.383M 34.01% | -9.545M 49.11% | -6.19M 59.90% | -6.365M 52.86% | -4.499M 63.67% | -4.06M 57.47% | -3.62M 41.52% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-108.23%
EPS Next 5 Year
18.49%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
53.32%
Revenue Next 5 Year
52.38%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
27.74%
EBIT Next 5 Year
24.28%
DANIMER SCIENTIFIC INC / DNMR Forecast FAQ
What is the price target for DNMR stock?
8 analysts have analysed DNMR and the average price target is 4.76 USD. This implies a price increase of 15.25% is expected in the next year compared to the current price of 4.13.
Can you provide the consensus estimates for DANIMER SCIENTIFIC INC next earnings?
The consensus EPS estimate for the next earnings of DANIMER SCIENTIFIC INC (DNMR) is -6.6 USD and the consensus revenue estimate is 11.27M USD.
How do analysts rate DANIMER SCIENTIFIC INC (DNMR)?
The consensus rating for DANIMER SCIENTIFIC INC (DNMR) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.